Medi Assist Ser.

Why is Medi Assist Healthcare Services Ltd falling/rising?

As of 09-Aug, Medi Assist Healthcare Services Ltd's stock price is declining at 364.55, down 0.82%, following a trend reversal after two days of gains. Despite some positive financial growth, the stock has underperformed significantly over the long term, with a year-to-date decline of 20.70% and negative sentiment due to decreased investor participation and lagging behind market benchmarks.

As of 09-Aug, Medi Assist Healthcare Services Ltd is experiencing a decline in its stock price, currently at 364.55, down by 3.0 points or 0.82%. This drop follows a trend reversal after two consecutive days of gains. The stock has underperformed its sector by 1.4% today and has shown a significant decrease in investor participation, with delivery volume falling by 31.73% compared to the 5-day average.<BR><BR>Despite some positive financial indicators, such as a 26.11% growth in net sales over the last six months and a higher profit after tax, the stock has struggled in the long term, with a year-to-date decline of 20.70% and a one-year return of -33.08%. This underperformance is compounded by the fact that it has consistently lagged behind the broader market benchmarks, including the BSE500.<BR><BR>Additionally, while the stock is trading at a discount compared to its peers, the overall sentiment appears to be negative due to its below-par performance in both the near and long term. The high institutional holdings at 72.66% suggest that these investors, who typically have better analytical resources, may also be cautious about the stock's future prospects, contributing to the current downward pressure on its price.

Which are the latest news on Medi Assist Ser.?

Should I buy, sell or hold Medi Assist Healthcare Services Ltd?

When is the next results date for Medi Assist Healthcare Services Ltd?

The next results date for Medi Assist Healthcare Services Ltd is 08 August 2026.

The next results date for Medi Assist Healthcare Services Ltd is scheduled for 08 August 2026.

What does Medi Assist Ser. do?

Medi Assist Healthcare Services Ltd is a small-cap insurance company that provides healthcare services, reporting net sales of 242 Cr and a net profit of 53 Cr for the quarter ending March 2026. It has a market cap of INR 2,631 Cr and key metrics include a P/E ratio of 28.00 and a debt-equity ratio of 0.06.

Overview:<BR>Medi Assist Healthcare Services Ltd operates in the insurance industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was incorporated in 2000 as "Net Logistics Private Limited" and later changed its name to "Medi Assist Healthcare Services Private Limited" in 2012. Upon converting to a public limited company, it adopted its current name on March 20, 2018. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 242 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 53 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 2,631 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 28.00<BR>- Industry P/E: 32<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.06<BR>- Return on Equity: 11.31%<BR>- Price to Book: 3.16<BR><BR>Contact Details:<BR>No Company Details Available. Registrar Address: Not available.

How big is Medi Assist Ser.?

As of 10th June, Medi Assist Healthcare Services Ltd has a market capitalization of 2,631.00 Cr, with recent net sales of 904.78 Cr and a net profit of 87.96 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Medi Assist Healthcare Services Ltd has a market capitalization of 2,631.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 904.78 Cr, while the sum of Net Profit for the same period is 87.96 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds stand at 541.47 Cr, and Total Assets are valued at 1,144.57 Cr.

Who are the peers of the Medi Assist Ser.?

Medi Assist Ser.'s peers include HDFC Life Insur., ICICI Lombard, ICICI Pru Life, General Insuranc, Max Financial, Star Health Insu, Go Digit General, New India Assura, and Niva Bupa Health. Medi Assist has average growth and management risk, with a 1-year return of -29.51%, lower than its peers.

Peers: The peers of Medi Assist Ser. are HDFC Life Insur., ICICI Lombard, ICICI Pru Life, General Insuranc, Max Financial, Star Health Insu, Go Digit General, New India Assura, Niva Bupa Health.<BR><BR>Quality Snapshot: Excellent management risk is observed at ICICI Lombard and Go Digit General, while Good management risk is found at Medi Assist Ser. Average management risk is present at HDFC Life Insur., ICICI Pru Life, General Insuranc, Max Financial, Star Health Insu, and Niva Bupa Health, and Below Average management risk is noted at New India Assura. Growth is Good at Go Digit General and Niva Bupa Health, Average at Medi Assist Ser., HDFC Life Insur., General Insuranc, and ICICI Lombard, while Below Average growth is seen at ICICI Pru Life, Max Financial, and Star Health Insu. All peers maintain an Excellent capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Star Health Insu at 12.98%, while the lowest is ICICI Pru Life at -27.67%. Medi Assist Ser. has a 1-year return of -29.51%, which is lower than both of these peers. Additionally, HDFC Life Insur., ICICI Pru Life, Max Financial, Go Digit General, New India Assura, and Medi Assist Ser. all have negative six-month returns.

Are Medi Assist Healthcare Services Ltd latest results good or bad?

Medi Assist Healthcare Services Ltd's latest results show strong revenue growth and a significant profit increase, but declining operating margins and reliance on a tax reversal raise concerns about sustainability, leading to cautious investor sentiment. The stock has also underperformed in the market, indicating potential challenges ahead.

Medi Assist Healthcare Services Ltd's latest results present a mixed picture. On one hand, the company reported a significant net profit of ₹53.44 crore for Q4 FY26, which is a remarkable increase of 1,181.53% quarter-on-quarter. Additionally, the revenue growth of 28.13% year-on-year indicates strong topline momentum, reflecting the company's successful penetration in the health insurance intermediary space.<BR><BR>However, there are notable concerns. The operating margin has decreased from 21.57% to 19.94% year-on-year, primarily due to rising employee costs that have outpaced revenue growth. This deterioration in operational efficiency raises questions about the company's ability to maintain profitability amidst increasing costs.<BR><BR>Furthermore, despite the impressive profit figures, a significant portion of this profit was influenced by a tax reversal, which may not reflect the underlying operational health of the business. Without this one-time benefit, the normalized net profit would have been considerably lower, suggesting that the company faces ongoing challenges.<BR><BR>The stock has also underperformed over the past year, declining 12.83% compared to a smaller drop in the broader market, indicating investor skepticism about its growth sustainability. The technical outlook remains bearish, with the stock trading below major moving averages.<BR><BR>In summary, while the latest results show strong revenue growth and a substantial profit increase, the underlying margin pressures and operational challenges suggest caution for investors.

Is Medi Assist Ser. technically bullish or bearish?

As of December 2, 2025, Medi Assist Ser. shows a mildly bearish trend with a bearish MACD and Bollinger Bands, despite some daily bullish signals, and has significantly underperformed against the Sensex.

As of 2 December 2025, the technical trend for Medi Assist Ser. has changed from sideways to mildly bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and both the weekly and monthly Bollinger Bands confirm a bearish outlook. The daily moving averages indicate a mildly bullish sentiment, but this is overshadowed by the overall bearish indicators. The stock has underperformed significantly against the Sensex over multiple time frames, further supporting the bearish sentiment.

How has been the historical performance of Medi Assist Ser.?

Medi Assist Ser. has shown consistent growth over the past four years, with net sales increasing from 393.81 Cr in Mar'22 to 723.32 Cr in Mar'25, and profit after tax rising from 63.47 Cr to 91.60 Cr. The company also improved its cash flow significantly, reaching 138 Cr in Mar'25.

Answer:<BR>The historical performance of Medi Assist Ser. shows a consistent growth trajectory in key financial metrics over the past four years.<BR><BR>Breakdown:<BR>Medi Assist Ser. has demonstrated significant growth in net sales, increasing from 393.81 Cr in Mar'22 to 723.32 Cr in Mar'25. The total operating income followed a similar trend, rising from 393.81 Cr in Mar'22 to 723.32 Cr in Mar'25. Total expenditure, excluding depreciation, also increased from 302.59 Cr in Mar'22 to 569.21 Cr in Mar'25, with employee costs rising notably from 155.68 Cr to 305.86 Cr during the same period. Operating profit (PBDIT) grew from 91.22 Cr in Mar'22 to 177.87 Cr in Mar'25, reflecting a robust operating profit margin that slightly improved from 23.16% to 21.31%. Profit before tax increased from 80.69 Cr in Mar'22 to 111.79 Cr in Mar'25, while profit after tax rose from 63.47 Cr to 91.60 Cr. The consolidated net profit also saw an increase from 64.22 Cr in Mar'22 to 90.88 Cr in Mar'25, with earnings per share growing from 9.33 to 12.89. On the balance sheet, total assets rose from 592.71 Cr in Mar'22 to 1,144.57 Cr in Mar'25, alongside total liabilities increasing from 592.71 Cr to 1,144.57 Cr. Cash flow from operating activities improved significantly, reaching 138 Cr in Mar'25 compared to 64 Cr in Mar'22, while cash and cash equivalents at the end of Mar'25 stood at 83 Cr, up from 14 Cr in Mar'22. Overall, Medi Assist Ser. has shown strong financial performance with consistent growth in sales, profits, and cash flow over the years.

Is Medi Assist Ser. overvalued or undervalued?

As of November 6, 2025, Medi Assist Ser. is considered overvalued with a valuation grade of "expensive," reflected in its high PE ratio of 46.86 and underperformance of -11.59% year-to-date compared to the Sensex's gain of 6.62%.

As of 6 November 2025, the valuation grade for Medi Assist Ser. has moved from very expensive to expensive, indicating a slight shift in perception but still suggesting a high valuation. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE ratio of 46.86, an EV to EBITDA ratio of 21.50, and a Price to Book Value of 0.66, which highlight the premium at which the stock is trading relative to its earnings and book value.<BR><BR>In comparison to peers, Medi Assist Ser. has a significantly higher PE ratio than Altius Telecom, which stands at 56.22, and a much lower EV to EBITDA ratio compared to Mindspace Business at 28.2. This suggests that while Medi Assist Ser. is expensive, its valuation is not as extreme as some of its peers. Additionally, the company's stock has underperformed relative to the Sensex, with a year-to-date return of -11.59% compared to the Sensex's gain of 6.62%, reinforcing the notion that the stock may be overvalued in the current market environment.

Who are the top shareholders of the Medi Assist Ser.?

The top shareholders of Medi Assist Ser. include mutual funds holding 25.12%, foreign institutional investors with 13.26%, and Bessemer India Capital Holdings II Ltd as the largest promoter with 15.68%. HDFC Large and Mid Cap Fund is the largest public shareholder at 7.79%, while individual investors hold 14.69%.

The top shareholders of Medi Assist Ser. include several key players. The majority of the shares are held by mutual funds, specifically through 13 schemes, which account for 25.12% of the total shares. The foreign institutional investors (FIIs) hold 13.26% through 46 different FIIs. <BR><BR>The promoter with the highest holding is Bessemer India Capital Holdings II Ltd, which owns 15.68% of the company. Among public shareholders, the HDFC Large and Mid Cap Fund is the largest, holding 7.79%. Additionally, individual investors collectively hold 14.69% of the shares.

Has Medi Assist Ser. declared dividend?

Medi Assist Healthcare Services Ltd has declared an 80% dividend, amounting to ₹4 per share, with an ex-date of September 6, 2024. However, the company's total returns have been negative in the short term, with a -16.97% return over the last 6 months and a -2.35% return over the past year.

Medi Assist Healthcare Services Ltd has declared an 80% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 80%<BR>- Amount per share: 4<BR>- Ex-date: 06 Sep 24<BR><BR>Dividend Yield: 0.81%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -16.97%, the dividend return was 0%, resulting in a total return of -16.97%.<BR><BR>Over the past year, the price return was -3.09%, the dividend return was 0.74%, leading to a total return of -2.35%.<BR><BR>For the 2-year period, there was no price return, no dividend return, and thus a total return of 0.0%.<BR><BR>In the 3-year period, the price return was 0%, the dividend return was 0%, resulting in a total return of 0.0%.<BR><BR>Over the last 4 years, the price return remained at 0%, with no dividend return, leading to a total return of 0.0%.<BR><BR>In the 5-year period, there was no price return, no dividend return, and therefore a total return of 0.0%.<BR><BR>Overall, while Medi Assist has declared a dividend, the total returns over various periods indicate a challenging performance, particularly in the short term, with significant negative price returns in the last 6 months and modest returns over the past year.